celecoxib has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, R | 1 |
| Thota, S | 1 |
| Bansal, R | 1 |
| Moghaddamt, HF | 1 |
| Ardestani, MS | 1 |
| Saffari, M | 1 |
| Navidpour, L | 1 |
| Shafiee, A | 1 |
| Rahmim, A | 1 |
2 other studies available for celecoxib and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Studies on 16,17-Pyrazoline Substituted Heterosteroids as Anti-Alzheimer and Anti-Parkinsonian Agents Using LPS Induced Neuroinflammation Models of Mice and Rats.
Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Brain; Celecoxib; Dexamethasone; Drug Evaluation, | 2018 |
Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.
Topics: Animals; Celecoxib; Corpus Striatum; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors | 2008 |